1492 Capital Management’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

1492 Capital Management’s Portfolio PLXP Stock Details PLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-7,096	Closed	-$823K	–	123
2016 Q3	$823K	Buy	7,096 +3,263	+85%	+$318K	0.67%	37
2016 Q2	$304K	Sell	3,833 -371	-9%	-$32.2K	0.27%	74
2016 Q1	$320K	Sell	4,204 -148	-3%	-$9.41K	0.27%	72
2015 Q4	$390K	Sell	4,352 -398	-8%	-$38.2K	0.28%	73
2015 Q3	$532K	Buy	+4,750	New	+$547K	0.38%	67

Other funds holding PLXP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AIM

Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Middleton & Co Boston, Massachusetts $877M AUM 15.2% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

1492 Capital Management's PLXP Position: Q4 2016 in Review

1492 Capital Management sold out of PLx Pharma Inc. Common Stock (PLXP) in Q4 2016, closing a stake of 7,096 shares — an estimated $823K sold.

1492 Capital Management first reported a position in PLXP in Q3 2015 and held it in 5 quarters. The position peaked at $823K in Q3 2016. 19 funds tracked by Wall St. Rank hold PLXP as of Q4 2016.

1492 Capital Management reported no remaining PLx Pharma Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
1492 Capital Management sold 7,096 PLx Pharma Inc. Common Stock shares in Q4 2016, an estimated $823K.
1492 Capital Management first reported a position in PLx Pharma Inc. Common Stock in Q3 2015 and held it in 5 quarters.
1492 Capital Management's PLx Pharma Inc. Common Stock position peaked at $823K in Q3 2016.
19 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q4 2016.

Based on 1492 Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.